| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 04/13/2011 | CN102015662A 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases |
| 04/13/2011 | CN102015661A Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 04/13/2011 | CN102010378A Preparation method of quizalofop-p-ethyl |
| 04/13/2011 | CN102010377A Method for preparing high-purity white 2-hydroxy quinoxaline crystal |
| 04/13/2011 | CN102010376A Synthesis of ionic liquid aqueous phase catalysis quinoxaline compound |
| 04/13/2011 | CN101421230B Novel phenyl-propargylether derivatives |
| 04/12/2011 | CA2475619C Piperidine derivatives |
| 04/07/2011 | WO2011038572A1 Novel compounds |
| 04/07/2011 | US20110082295 Novel curcumin derivative |
| 04/07/2011 | US20110082156 Fatty acid acipimox derivatives and their uses |
| 04/07/2011 | US20110082142 Selective kinase inhibitors |
| 04/07/2011 | CA2775753A1 Novel compounds |
| 04/06/2011 | EP2305653A1 Therapeutic agent for chronic renal failure |
| 04/06/2011 | EP2303880A2 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same |
| 04/06/2011 | EP1303479B1 7-, 8- and 9-substituted tetracycline compounds |
| 04/06/2011 | EP1219607B1 Integrase inhibitors containing aromatic heterocycle derivatives |
| 04/06/2011 | CN1918135B Aminoquinoxaline compound, polyaminoquinoxaline compound, and use thereof |
| 04/06/2011 | CN1730476B Aromatic amine ketone compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/06/2011 | CN102002038A Ligustrazine nitrogen (oxygen) heteroatom alkylation derivative as well as preparation method and application thereof |
| 04/06/2011 | CN102002006A Method for preparing 2,3-dimethyl pyrazine |
| 04/06/2011 | CN102002005A Preparation method for 2,5-lupetazin |
| 04/06/2011 | CN101151270B Organometallic complex and light emitting element using the same, and electronic device |
| 04/05/2011 | US7919619 Nonlinear optic chromophores of heterocyclic multiring system including a organic electron donating group, an organic electron accepitn group; first-order hyperpolarizability; electrooptics |
| 04/05/2011 | US7919528 Antibiotic; bactericides |
| 04/05/2011 | US7919493 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent |
| 04/05/2011 | CA2467269C Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011035941A1 Lysine specific demethylase-1 inhibitors and their use |
| 03/31/2011 | WO2010083328A3 Methods for screening and compounds that protect against amyloid diseases |
| 03/31/2011 | CA2812683A1 Lysine specific demethylase-1 inhibitors and their use |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/30/2011 | EP2300430A1 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/30/2011 | EP2300011A1 Therapeutic methods and compounds |
| 03/30/2011 | EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 03/30/2011 | EP1558586B1 Inhibitors of akt activity |
| 03/30/2011 | EP0933354B1 Calcium receptor-active compounds |
| 03/30/2011 | CN1966500B Quinoxaline derivative, preparation method and uses |
| 03/29/2011 | US7915450 Transfection reagents |
| 03/29/2011 | US7915443 Sulfoximines as kinase inhibitors |
| 03/29/2011 | US7915253 4-[2,6-Dimethyl-4-(4-trifluoromethoxy-phenyl)-piperazine-1-sulfonyl]-indan-2-carboxylic acid; peroxisome proliferator activated receptors modulator; antidiabetic, antiinflammatory agent; obesity, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome, ischemia-associated organ injury |
| 03/29/2011 | US7914706 Charge transport compositions and electronic devices made with such compositions |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/24/2011 | WO2010091384A3 Cadherin-11 inhibitors and methods of use thereof |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071125 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity |
| 03/23/2011 | EP2298779A1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes |
| 03/23/2011 | EP2298728A1 Transfection reagents |
| 03/23/2011 | EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives |
| 03/23/2011 | EP2297105A1 Substituted amides, method of making, and use as btk inhibitors |
| 03/23/2011 | EP2296653A1 Compounds and methods for treating inflammatory and fibrotic disorders |
| 03/23/2011 | EP1140836B1 Amide compounds |
| 03/23/2011 | CN1942436B Lysine based compounds |
| 03/22/2011 | US7910735 insecticides or acaricides; claimed intermediates are a 3-alkyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]aniline and a pyrazine-2-carboxylic acid |
| 03/22/2011 | US7910592 CETP inhibitors |
| 03/22/2011 | US7910587 Serine protease inhibitors; replication inhibition |
| 03/22/2011 | CA2480880C Inhibitors of akt activity |
| 03/22/2011 | CA2432572C Oxybenzamides derivatives as factor xa inhibitors |
| 03/17/2011 | US20110065710 Insecticidal N-(Heteroarylalkyl)Alkanediamine Derivatives |
| 03/17/2011 | US20110065691 Therapeutic piperazines |
| 03/17/2011 | US20110065689 Therapeutic piperazines |
| 03/17/2011 | US20110065681 Amide compounds, compositions and uses thereof |
| 03/17/2011 | US20110064892 Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base |
| 03/16/2011 | EP2295402A2 Antibacterial agents |
| 03/16/2011 | EP2205562B1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 03/16/2011 | EP1448535B1 Benzamide and heteroarylamide as p2x7 receptor antagonists |
| 03/16/2011 | CN101362724B Tetramethylpyrazine acidamides derivates, preparation method and medicament composition and application |
| 03/15/2011 | US7906645 Heterocyclic compounds as ccr2b antagonists |
| 03/15/2011 | US7906513 Prevent reproduction; breaking life cycle;viricides |
| 03/15/2011 | US7906235 Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 03/15/2011 | CA2502769C 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
| 03/15/2011 | CA2471814C Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient |
| 03/10/2011 | WO2011027888A1 Diamide-phenyl derivative and pharmaceutically acceptable salt thereof |
| 03/10/2011 | WO2011026959A1 Novel ethane diamine hepcidin antagonists |
| 03/10/2011 | WO2011026241A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | WO2011026240A1 Oxopiperazine derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | US20110060019 Heteroaryl-ureas and their use as glucokinase activators |
| 03/10/2011 | US20110059989 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases |
| 03/10/2011 | US20110059972 1,4-naphthoquinones derivatives and therapeutic use thereof |
| 03/10/2011 | US20110059957 Benzene or thiophene derivative and use thereof as vap-1 inhibitor |
| 03/10/2011 | CA2771592A1 Substituted heterocyclic derivatives for the treatment of pain and epilepsy |
| 03/10/2011 | CA2771472A1 Oxopiperazine derivatives for the treatment of pain and epilepsy |
| 03/09/2011 | EP2292231A1 Therapeutic agent for spinal canal stenosis |
| 03/09/2011 | EP2291351A1 Alpha-mercapto-amides |
| 03/09/2011 | EP1912954B1 Novel cysteine protease inhibitors and their therapeutic applications |
| 03/09/2011 | EP1585730B1 Carboxamide derivatives and their use as factor xa inhibitors |
| 03/08/2011 | US7902372 Therapy for obesity; using a secondary amino compound |
| 03/08/2011 | US7902368 Cationic substituted 2,2,6,6-tetraalkylpiperidinyl alkoxyamines |
| 03/08/2011 | US7902196 Synthesis of avrainvillamide, strephacidin B, and analogues thereof |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/03/2011 | WO2011024874A1 Base addition salts |
| 03/03/2011 | WO2011024078A1 3 -oxopiperazinium derivatives as agonists of nerve growth factor and their use as medicaments |
| 03/03/2011 | WO2011023706A1 Process for the preparation of a glucokinase activator compound |
| 03/03/2011 | WO2011002145A3 Absorbent for separating acid gas |
| 03/03/2011 | WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors |
| 03/03/2011 | US20110054174 Process for the preparation of a glucokinase activator compound |
| 03/03/2011 | US20110053958 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
| 03/03/2011 | US20110053957 Malonate salt of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same |
| 03/03/2011 | US20110053947 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 03/03/2011 | US20110053918 Gamma secretase modulators |